What it's for (Indications)
- Loxoprofen sodium, a non-steroidal anti-inflammatory drug (NSAID) of the propionic acid derivative class, is indicated for the symptomatic treatment of various pain and inflammatory conditions.
- These include, but are not limited to, rheumatoid arthritis, osteoarthritis, low back pain, shoulder-arm-neck syndrome, and toothache.
- It is also extensively used for post-operative, post-traumatic, and post-extraction pain management, offering effective analgesia and anti-inflammatory action.
- Furthermore, loxoprofen sodium can be prescribed for the symptomatic relief of pain and fever associated with acute upper respiratory tract inflammation and for the management of dysmenorrhea, providing relief from menstrual cramps and related discomfort.
- Its utility spans a broad spectrum of acute and chronic pain and inflammatory disorders, serving as a critical therapeutic option.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The typical recommended oral dosage for loxoprofen sodium in adults is 60 mg, administered two to three times daily. The dosage should always be individualized based on the patient's age, symptoms, and the severity of the condition being treated, with careful consideration for the lowest effective dose for the shortest possible duration. While the standard daily dose usually does not exceed 180 mg, healthcare providers may adjust this based on clinical judgment and patient response. It is crucial for patients to adhere strictly to their prescribed dosing regimen and to not exceed the maximum recommended daily dose to minimize the risk of adverse effects. Administration after meals is generally recommended to reduce potential gastrointestinal irritation, although specific instructions from a physician or pharmacist should always be followed. |
Safety & Warnings
Common Side Effects
- Loxoprofen sodium, like other NSAIDs, is associated with a range of potential side effects, primarily affecting the gastrointestinal system.
- Common adverse reactions include abdominal discomfort, nausea, vomiting, indigestion (dyspepsia), diarrhea, and constipation.
- More serious, albeit less common, gastrointestinal side effects can involve gastrointestinal bleeding, ulceration, and perforation, which can be life-threatening.
- Other potential systemic effects include renal impairment, fluid retention, edema, and hypertension.
- Cardiovascular thrombotic events, such as myocardial infarction and stroke, have also been reported.
- Hypersensitivity reactions, ranging from skin rashes to severe anaphylaxis, are possible.
- Patients may also experience central nervous system effects like dizziness or headache, hepatic dysfunction, and hematologic abnormalities.
- Any persistent or severe side effects should be promptly reported to a healthcare professional.
Serious Warnings
- Black Box Warning: As with other non-steroidal anti-inflammatory drugs (NSAIDs), loxoprofen sodium carries specific Black Box Warnings issued by regulatory authorities due to serious potential risks. **CARDIOVASCULAR THROMBOTIC EVENTS:** NSAIDs, including loxoprofen sodium, cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction (MI) and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk. Loxoprofen sodium is contraindicated in the setting of coronary artery bypass graft (CABG) surgery. **GASTROINTESTINAL RISK:** NSAIDs, including loxoprofen sodium, cause an increased risk of serious gastrointestinal (GI) adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients and patients with a prior history of peptic ulcer disease and/or GI bleeding are at greater risk for serious GI events. Clinicians should be vigilant for signs of GI bleeding and discuss these risks thoroughly with patients before initiating therapy.
- Careful consideration and patient monitoring are paramount when prescribing loxoprofen sodium due to several significant warnings.
- Patients with a history of gastrointestinal diseases, such as peptic ulcers or GI bleeding, are at an increased risk of serious gastrointestinal events.
- Cardiovascular risks, including the potential for thrombotic events, hypertension, and exacerbation of heart failure, necessitate cautious use, especially in patients with pre-existing cardiovascular conditions.
- Renal toxicity, hepatic dysfunction, and fluid retention with edema are also important considerations, requiring careful assessment of renal and hepatic function, particularly in elderly patients or those with compromised organ systems.
- Hypersensitivity reactions, including severe anaphylactoid reactions, may occur.
- Loxoprofen sodium should be used with extreme caution in elderly individuals due to their increased susceptibility to adverse effects.
- Furthermore, it should be avoided in the third trimester of pregnancy due to potential harm to the fetus and complications during labor and delivery.
- Concomitant use with other medications, such as anticoagulants, antiplatelets, diuretics, ACE inhibitors, and methotrexate, requires close monitoring for drug interactions and increased adverse event risk.
- Patients should be advised to report any unusual symptoms promptly.
How it Works (Mechanism of Action)
Loxoprofen sodium exerts its therapeutic effects primarily through the inhibition of prostaglandin synthesis. It is classified as a prodrug, meaning it is pharmacologically inactive upon administration and requires metabolic conversion to its active form. Upon absorption, loxoprofen is rapidly reduced to its active metabolite, trans-OH loxoprofen, which is a potent non-selective inhibitor of cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2. By inhibiting these enzymes, trans-OH loxoprofen prevents the conversion of arachidonic acid into prostaglandins, which are key mediators of inflammation, pain, and fever. The reduction in prostaglandin production subsequently leads to decreased inflammatory responses, significant analgesic effects by reducing pain perception, and antipyretic action through the modulation of thermoregulatory centers. This dual inhibition of COX isoforms underlies its broad efficacy in managing inflammatory and painful conditions.